Drug Trial Radar · NCT00461526
Diarrhea Predominant Irritable Bowel Syndrome in Females
Last checked: Nov 19, 2026Latest source record: Nov 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
240
Actual
Start
Oct 2006
Primary completion
Dec 2007
Study completion Dec 2007
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 18, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Clinical Trial with TRN-002 in Women with Irritable Bowel Syndrome (IBS) The purpose of this study is to investigate the safety and effectiveness of a new investigational drug in women for the treatment of diarrhea-predominant irritable bowel syndrome. The investigational drug is a natural product taken from a plant that grows in South America. The study medication will be administered orally twice a day. Subjects will be not able to remain on certain standard IBS medications (anti-diarrheals) while participating in the study. The total duration of the study is 18 weeks. The study requires five study visits that include physical exams, ECG, blood draws, laboratory studies, and a colon procedure (such as a colonoscopy or flexible sigmoidoscopy if an appropriate procedure has not been performed in the last 5 years.) Participants will be asked to make entries into a touch-tone telephone diary on a daily basis. Participants must meet all of the following criteria: * Females at least 18 years of age * Diagnosis of diarrhea predominant Irritable Bowel Syndrome * Willingness to make daily calls on a touch-tone telephone * Willingness to have an endoscopic and/or radiologic bowel evaluation, if you have not received one in the past 5 years. * Willingness to take an approved method of birth control (if required) Participants CANNOT meet any of the following criteria: * Serious medical or surgical conditions * Colon Cancer, Crohns Disease or Ulcerative Colitis * Pregnant or breast feeding
Conditions
- Irritable Bowel Syndrome
Interventions
crofelemerDrug
125 mg crofelemer vs. placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the safety of TRN-002 when administered twice daily for 12 consecutive weeks.Time frame: March 2008
- To assess the efficacy of TRN-002 when administered twice daily for 12 consecutive weeks.Time frame: March 2008
Locations
43 sites in 1 country. Site status is shown where the registry gives one.
Clinical Research Associates, LLC
Huntsville, Alabama
Radiant Research
Chandler, Arizona
Genova Clinical Research
Tucson, Arizona
Advanced Clinical Research Institute
Anaheim, California
Community Clinical Trials
Orange, California
Advanced Clinical Research Institute
Orange, California
Medical Associates Research Group
San Diego, California
Boulder Medical Center, PC
Boulder, Colorado
Rocky Mountain Gastroenterology Associates
Thornton, Colorado
Litchfield County Gastroenterology Associates, LLC
Torrington, Connecticut
Washington Gastroenterology, PC
Washington D.C., District of Columbia
Consultants of Clinical Research of South Florida
Boynton Beach, Florida
University Clinical Research - DeLand
DeLand, Florida
Stedman Clinical Trials
Tampa, Florida
Mount Vernon Clinical Research
Atlanta, Georgia
Clinical Research Atlanta
Stockbridge, Georgia
Digestive and Liver Disease Consultants, PC
Clive, Iowa
Trover Center for Clinical Studies
Madisonville, Kentucky
Maryland Digestive Disease Research
Laurel, Maryland
Gastroenterology Associates
Jackson, Mississippi
Toby Village Office Park
Pittsford, New York
LeBauer Research Associates, PA
Greensboro, North Carolina
Vital re:Search
Greensboro, North Carolina
Bethany Medical Center
High Point, North Carolina
Hanover Medical Specialist, PA
Wilmington, North Carolina
Piedmont Medical Research Associates
Winston-Salem, North Carolina
Akron Gastroenterology Associates, Inc.
Akron, Ohio
Research Solutions Corp.
Cincinnati, Ohio
Gastrointestinal & Liver Disease Consultants
Dayton, Ohio
Oklahoma Foundation for Digestive Research
Oklahoma City, Oklahoma
Sooner Clinical Research
Oklahoma City, Oklahoma
Grand View Medical Research
Sellersville, Pennsylvania
Anderson Gastroenterology Associates, LLC
Anderson, South Carolina
ClinSearch
Chattanooga, Tennessee
Gastroenterology Center of the MidSouth, PC
Germantown, Tennessee
Memphis Gastroenterology Group
Germantown, Tennessee
The Jackson Clinic
Jackson, Tennessee
Gastroenterology Associates
Kingsport, Tennessee
Austin Gastroenterology, PA
Austin, Texas
Trinity Clinic - Corsicana
Corsicana, Texas
Showing 40 of 43 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.